SARS-CoV-2 spike mRNA vaccine sequences circulate in blood up to 28 days after COVID-19 vaccination, according to…
Tag: Pfizer
Pfizer and BioNTech Initiate Phase 1 Study of Single Dose mRNA-Based Combination Vaccine Candidate for Influenza and COVID-19
The BioNTech-sponsored, randomized Phase 1 study is designed to evaluate the safety, immunogenicity, and optimal dose…
Bil-Filmat-Il-Kummisjoni Ewropea jistqarru li l-vaċċin tal-Covid19 ma jwaqqafx it-trasmissjoni
Skont l-awtoritajiet tas-saħħa pubblika, kienu jirrakkomandaw li wieħed għandu jitlaqqam sabiex jitnaqqas ir-riskju tat-trasmissjoni. Kien hemm…
Profs Gauci qalet li Malta m’ għamlux due diligence iżda qagħdu fuq l-Ewropa
Il-kumpanija Pfizer qatt ma għamlet testing fit-trials fuq il-vaċċini tal-Covid19 biex ikunu jafu jekk it-trażmissjoni tiġix…
Pfizer and BioNTech clinical studies for a new COVID-19 RNA Booster Dose
A phase 2 study on an improved version of the mRNA vaccine developed by two businesses…
Pfizer u BioNTech b’arranġament ġdid mal-Istati Uniti għall mewġa tal-Covid19 li jmiss
Fid-29 ta’ Ġunju,NEW YORK u MAINZ, il-Ġermanja–(BUSINESS WIRE)– Pfizer Inc. (NYSE: PFE) u BioNTech SE (Nasdaq:…
Vaccines Agreements
We addressed the Advance Purchase Agreement (APA) and Purchase Agreement (PA) on our live-stream with Mario…
It-Transparenza tal-kuntratti tal-vaċċini tal-COVID-19 u id-drittijiet fundamentali taċ-ċittadini tal-UE.
Il-Kumitat COVI laqa’ lill-Viċi President għall-Valuri u t-Trasparenza Věra Jourová fil-21 ta’ Ġunju 2022 għal skambju…
FDA approves Pfizer Booster for Kids 5 to 11, bypassing advisory panel.
After analysing data from an ongoing Pfizer research, the FDA decided to approve a third shot…
Pfizer vaccine loses its effectiveness against omicron within weeks
According to a research, the Pfizer vaccine loses its effectiveness against omicron within weeks. Immunity conferred…